LambdaTest Integrates with Assembla to Streamline Bug Tracking for Development Teams
This Integration enables teams with seamless bug tracking capabilities directly from the testing environment, enhancing collaboration and accelerating software delivery cycles.
LambdaTest, a unified agentic AI and cloud engineering platform, has announced its partnership with Assembla, a robust cloud-based platform for version control and project management. This collaboration enables software development teams to streamline their bug tracking processes and improve overall productivity.
LambdaTest offers developers an exhaustive list of cloud-based testing solutions, including cross-browser compatibility testing, Web and App automation testing, and Real Device testing. Assembla users can now easily integrate with the LambdaTest platform to seamlessly mark bugs with detailed screenshots and assign them to team members.
"This integration between LambdaTest and Assembla allows development teams to optimize their testing and bug tracking processes," said Mayank Bhola, Co-Founder and Head of Product at LambdaTest. "By connecting these platforms, teams can maintain uninterrupted workflow while ensuring thorough documentation and tracking of issues discovered during testing, ultimately delivering higher quality software at accelerated speeds."
Will Baizer, General Manager, Assembla, said, "We are pleased to collaborate with LambdaTest to provide our users with access to powerful testing capabilities. This collaboration enables our users to identify bugs earlier in the development cycle, document them with precise screenshots and details, and track them to resolution without switching platforms. This partnership enhances our users' ability to deliver higher quality applications while significantly reducing their testing overhead."
The integration between Assembla and LambdaTest is now available to all users, offering teams a seamless solution for testing applications and tracking bugs with unprecedented efficiency.
For more information about this integration, please visit https://www.lambdatest.com/support/docs/assembla-integration/
About LambdaTest
LambdaTest is an AI-native, omnichannel software quality platform that empowers businesses to accelerate time to market through intelligent, cloud-based test authoring, orchestration, and execution. With over 15,000 customers and 2.3 million users across 130+ countries, LambdaTest is the trusted choice for modern software testing.
- Browser & App Testing Cloud: Enables manual and automated testing of web and mobile apps across 10,000+ browsers, real devices, and OS environments, ensuring cross-platform consistency.
- HyperExecute: An AI-native test execution and orchestration cloud that runs tests up to 70% faster than traditional grids, offering smart test distribution, automatic retries, real-time logs, and seamless CI/CD integration.
- KaneAI: The world’s first GenAI-native testing agent, leveraging LLMs for effortless test creation, intelligent automation, and self-evolving test execution. It integrates directly with Jira, Slack, GitHub, and other DevOps tools.
For more information, please visit https://lambdatest.com
About Assembla
Assembla is a cloud-based platform that provides version control and project management tools specifically designed for software development teams. It supports multiple version control systems, such as Git, Subversion (SVN), and Perforce, allowing teams to manage their source code, track changes, and collaborate more efficiently.
For more information, please visit https://get.assembla.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250603273477/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Southwest Power Pool (SPP) Partners with Hitachi to Develop Advanced AI Solution for Critical Power Transmission Reliability and Flexibility Challenges5.6.2025 14:00:00 CEST | Press release
End-to-end use of industrial AI and advanced computing infrastructure to help significantly speed up safe integration and use of additional energy sources supporting central U.S. power grids. Initial partnership objectives are to reduce generator interconnection analysis times by 80% while facilitating more informed decision-making. Objective to be achieved via advanced AI solutions from Hitachi, powered by NVIDIA’s accelerated computing platform. Integrated solution comprised of multiple Hitachi capabilities including an AI-based power simulation algorithm, Hitachi-iQ-accelerated calculations, augmented simulation modelling, predictive analytics, as well as design and engineering services. Wide-ranging impacts to address imminent U.S. energy infrastructure needs by increasing planning processes’ speed and efficiency; enabling SPP to better resolve energy capacity shortages, increase grid reliability, and improve emergency response capabilities. Subsequent partnership objectives to add
Sarah Harkcom, General Counsel at Scientist.com, Wins European Legal Innovation & Technology “Innovation Trailblazer” Award5.6.2025 13:55:00 CEST | Press release
Harkcom honored for creating the industry-standard legal framework that accelerates drug-discovery contracting worldwide Scientist.com, the leading R&D procurement-orchestration platform for the life sciences, today announced that its General Counsel, Sarah Harkcom, has been named Innovation Trailblazer at the 2025 European Legal Innovation & Technology Awards. Harkcom was recognized for architecting a unified, cross-border contracting model now adopted by many of the world’s top pharmaceutical companies and contract research organizations (CROs). The framework has already supported more than $2.5 billion in outsourced research, enabling scientists to launch critical experiments in days rather than weeks or months. “Sarah’s vision reshaped how the pharma industry does business,” said Kevin Lustig, PhD, CEO and Founder of Scientist.com. “Her streamlined legal model removes friction for both buyers and suppliers, giving researchers faster access to the services they need to discover life
Suzano and Kimberly-Clark Announce the Creation of a Global Tissue Company Operating in Over 70 Countries5.6.2025 13:11:00 CEST | Press release
New joint venture will be the owner of Kimberly-Clark’s international tissue assets, including 22 manufacturing facilities, approximately 9,000 employees, and marketing and selling regional and global brands, such as Kleenex, Scott and WypAll in over 70 countries.The strategic partnership will integrate Suzano’s industrial and operational expertise with Kimberly-Clark´s brand management and international experience across a range of markets. Suzano, the world’s largest pulp producer, and Kimberly-Clark, a global leader in the consumer staples industry, today announced the creation of a US$3.4 billion joint venture focused on the manufacture, marketing and distribution of consumer and professional tissue products, such as toilet paper, napkins, paper towels and facial tissues in over 70 countries. Suzano will acquire a 51 percent interest in the new entity, with Kimberly-Clark holding a 49 percent interest. Suzano will pay Kimberly-Clark US$1.734 billion in cash for its 51 percent stake
Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting5.6.2025 12:00:00 CEST | Press release
DAZALS did not meet its primary endpoint of improved outcome in the ALS Functional Rating Scale-Revised (ALSFRS-R) in patients who received dazucorilant compared to patients who received placeboDAZALS met its secondary endpoint of improved overall survival at week 24 of the study in patients who received 300 mg of dazucorilant compared to patients who received placeboExploratory analysis at the one-year mark shows continued significant improvement in overall survival between patients who received 300 mg of dazucorilant and those who received placebo onlyCorcept seeking guidance from United States and European regulators on optimum path forward Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, presented results from its DAZALS study of dazucorilant in patients with ALS at the Eu
Grocery Retailers See 3.8% Incremental Sales Growth With New Data-Driven Business Model5.6.2025 08:30:00 CEST | Press release
L - founders of loyalty leverages AI-powered retail data and consumer insights to help retailers navigate economic uncertainty, margin pressures and shifting customer behaviour Grocery retailers using L’s tactical loyalty campaigns have seen an average 3.8% like-for-like sales growth*, even as rising costs, global trade tensions and inflation put additional pressure on already thin margins. With tariffs and supply chain disruptions pushing up consumer prices, shoppers are prioritising value more than ever. "Retailers are navigating a perfect storm of rising costs and uncertain consumer behaviours," says Patrik Sundvisson, CEO of L - founders of loyalty. "With Total Store Impact, we go beyond building campaigns – we're offering a proven, data-driven approach to growing sales today and building brand equity for tomorrow." This shift comes at a critical time. As consumer spending habits turn toward value-driven purchasing, retailers must rethink their promotional strategies to differentia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom